Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First preclinical data on MEK inhibitor ARRY-142886 presented

April 7, 2004

Clofarabine NDA submission completed

April 7, 2004

Ardana acquires global rights to Teverelix

April 7, 2004

Promising tubulin-binding compound with antimitotic activity

April 7, 2004

RS-5444, a PPARgamma agonist, shows high affinity against thyroid tumor growth

April 7, 2004

CX-3543, a novel c-Myc oncogene inhibitor, shows efficacy in vivo

April 7, 2004

Inhibitors of CDK2 and other kinases emerge from Cyclacel R&D

April 7, 2004

Novel protein kinase inhibitors in early development at Vertex

April 7, 2004

Integrin antagonists show good potency, selectivity and bioavailability

April 7, 2004

Antitumor effects of the chemosensitizer phenoxodiol in prostate and ovarian cancer

April 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...